Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ogan

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Molecular classification of renal tumors by gene expression profilingAudrey N Schuetz, Qiqin Yin-Goen, Mahul B Amin, et al.
Asian Journal of Urology|February 2, 2018
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinomaRishi R Sekar, Dattatraya Patil, Yoram Baum, et al.
BMC Medical Education|March 28, 2026
Student perceptions and understanding of urology in the United Kingdom - SPARKReza Lahiji, Lally Iqbal, Bilal Safdar, et al.
Frontiers in Oncology|December 12, 2022
Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinomaBenjamin N Schmeusser, Eric Midenberg, Arnold R Palacios, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
The Oncologist|August 4, 2023
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia BiomarkerBenjamin N Schmeusser, Henry Biermann, Edouard H Nicaise, et al.
Cancer Medicine|February 27, 2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitorsJulie M Shabto, Dylan J Martini, Yuan Liu, et al.
Cancer|July 3, 2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiationDylan J Martini, Katherine B Case, Derrik Gratz, et al.
Clinical Genitourinary Cancer|May 20, 2023
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor ThrombusBenjamin N Schmeusser, Eric Midenberg, Arnold R Palacios, et al.
JCO Oncology Practice|June 15, 2026
Evaluating the Diagnostic Performance of Clear Cell Likelihood Score in Predicting Clear Cell Renal Cell Carcinoma Among Patients Younger Than 50 YearsAlexander Abdollahzadeh, Reza Lahiji, Matthew Harris, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Molecular Diagnostics : JMD|April 29, 2005
Molecular classification of renal tumors by gene expression profilingAudrey N Schuetz, Qiqin Yin-Goen, Mahul B Amin, et al.
Asian Journal of Urology|February 2, 2018
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinomaRishi R Sekar, Dattatraya Patil, Yoram Baum, et al.
BMC Medical Education|March 28, 2026
Student perceptions and understanding of urology in the United Kingdom - SPARKReza Lahiji, Lally Iqbal, Bilal Safdar, et al.
Frontiers in Oncology|December 12, 2022
Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinomaBenjamin N Schmeusser, Eric Midenberg, Arnold R Palacios, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
The Oncologist|August 4, 2023
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia BiomarkerBenjamin N Schmeusser, Henry Biermann, Edouard H Nicaise, et al.
Cancer Medicine|February 27, 2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitorsJulie M Shabto, Dylan J Martini, Yuan Liu, et al.
Cancer|July 3, 2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiationDylan J Martini, Katherine B Case, Derrik Gratz, et al.
Clinical Genitourinary Cancer|May 20, 2023
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor ThrombusBenjamin N Schmeusser, Eric Midenberg, Arnold R Palacios, et al.
JCO Oncology Practice|June 15, 2026
Evaluating the Diagnostic Performance of Clear Cell Likelihood Score in Predicting Clear Cell Renal Cell Carcinoma Among Patients Younger Than 50 YearsAlexander Abdollahzadeh, Reza Lahiji, Matthew Harris, et al.
Pageof 17